Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism

Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolism, clinical and experimental clinical and experimental, 2012-06, Vol.61 (6), p.762-775
Hauptverfasser: Hage, Mirella P, Salti, Ibrahim, El-Hajj Fuleihan, Ghada
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 775
container_issue 6
container_start_page 762
container_title Metabolism, clinical and experimental
container_volume 61
creator Hage, Mirella P
Salti, Ibrahim
El-Hajj Fuleihan, Ghada
description Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative.
doi_str_mv 10.1016/j.metabol.2011.11.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1017620544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026049511003659</els_id><sourcerecordid>1017620544</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-16b6602f4efd873ca3e47654cdeeb8770afac5aaba2e518f9b8093e2d18125523</originalsourceid><addsrcrecordid>eNqFkluL1DAUgIMo7rj6E5S-CL50PEmbpPXBRRZvsKCgPofT9NTN2DZjkgr996bMrIIvhgPhkO9c-AhjTznsOXD18rCfKGHnx70Azvc5APg9tuOyEmWjAO6zHYBQJdStvGCPYjwAgNaNesguRD68Ec2O4WcMmG7X4CdMPrr4qsAiYKBipVQcg-9Gyi_OFpScH_33tfBDEcguIdCcCpz74kghF6YtvV1zcrxr6XoXp8fswYBjpCfn-5J9e_f26_WH8ubT-4_Xb25KW0tIJVedUiCGmoa-0ZXFimqtZG17oq7RGnBAKxE7FCR5M7RdA21FoucNF1KK6pK9OPXNS_9cKCYzuWhpHHEmv0STrWklQNZ1RuUJtcHHGGgwx-AmDGuGNk6ZgznbNZtdkyPbzXXPziOWbqL-T9Wdzgw8PwMYLY5DwNm6-JeTrdKVVpm7OnGUhfxyFEy0jmZLvctqk-m9--8qr__pYEc3uzz0B60UD34Jc7ZtuInCgPmyfYXtJ3AOUCnZVr8BTzSx2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017620544</pqid></control><display><type>article</type><title>Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hage, Mirella P ; Salti, Ibrahim ; El-Hajj Fuleihan, Ghada</creator><creatorcontrib>Hage, Mirella P ; Salti, Ibrahim ; El-Hajj Fuleihan, Ghada</creatorcontrib><description>Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative.</description><identifier>ISSN: 0026-0495</identifier><identifier>EISSN: 1532-8600</identifier><identifier>DOI: 10.1016/j.metabol.2011.11.001</identifier><identifier>PMID: 22221828</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Endocrinology &amp; Metabolism ; Endocrinopathies ; Feeding. Feeding behavior ; Fundamental and applied biological sciences. Psychology ; Humans ; Hyperparathyroidism - etiology ; Hyperparathyroidism - surgery ; Medical sciences ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Parathyroid Glands - surgery ; Parathyroidectomy ; Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases) ; Recurrence ; Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><ispartof>Metabolism, clinical and experimental, 2012-06, Vol.61 (6), p.762-775</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-16b6602f4efd873ca3e47654cdeeb8770afac5aaba2e518f9b8093e2d18125523</citedby><cites>FETCH-LOGICAL-c450t-16b6602f4efd873ca3e47654cdeeb8770afac5aaba2e518f9b8093e2d18125523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0026049511003659$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25967376$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22221828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hage, Mirella P</creatorcontrib><creatorcontrib>Salti, Ibrahim</creatorcontrib><creatorcontrib>El-Hajj Fuleihan, Ghada</creatorcontrib><title>Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism</title><title>Metabolism, clinical and experimental</title><addtitle>Metabolism</addtitle><description>Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative.</description><subject>Biological and medical sciences</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Endocrinopathies</subject><subject>Feeding. Feeding behavior</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hyperparathyroidism - etiology</subject><subject>Hyperparathyroidism - surgery</subject><subject>Medical sciences</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Parathyroid Glands - surgery</subject><subject>Parathyroidectomy</subject><subject>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</subject><subject>Recurrence</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><issn>0026-0495</issn><issn>1532-8600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkluL1DAUgIMo7rj6E5S-CL50PEmbpPXBRRZvsKCgPofT9NTN2DZjkgr996bMrIIvhgPhkO9c-AhjTznsOXD18rCfKGHnx70Azvc5APg9tuOyEmWjAO6zHYBQJdStvGCPYjwAgNaNesguRD68Ec2O4WcMmG7X4CdMPrr4qsAiYKBipVQcg-9Gyi_OFpScH_33tfBDEcguIdCcCpz74kghF6YtvV1zcrxr6XoXp8fswYBjpCfn-5J9e_f26_WH8ubT-4_Xb25KW0tIJVedUiCGmoa-0ZXFimqtZG17oq7RGnBAKxE7FCR5M7RdA21FoucNF1KK6pK9OPXNS_9cKCYzuWhpHHEmv0STrWklQNZ1RuUJtcHHGGgwx-AmDGuGNk6ZgznbNZtdkyPbzXXPziOWbqL-T9Wdzgw8PwMYLY5DwNm6-JeTrdKVVpm7OnGUhfxyFEy0jmZLvctqk-m9--8qr__pYEc3uzz0B60UD34Jc7ZtuInCgPmyfYXtJ3AOUCnZVr8BTzSx2A</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Hage, Mirella P</creator><creator>Salti, Ibrahim</creator><creator>El-Hajj Fuleihan, Ghada</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism</title><author>Hage, Mirella P ; Salti, Ibrahim ; El-Hajj Fuleihan, Ghada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-16b6602f4efd873ca3e47654cdeeb8770afac5aaba2e518f9b8093e2d18125523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological and medical sciences</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Endocrinopathies</topic><topic>Feeding. Feeding behavior</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hyperparathyroidism - etiology</topic><topic>Hyperparathyroidism - surgery</topic><topic>Medical sciences</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Parathyroid Glands - surgery</topic><topic>Parathyroidectomy</topic><topic>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</topic><topic>Recurrence</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hage, Mirella P</creatorcontrib><creatorcontrib>Salti, Ibrahim</creatorcontrib><creatorcontrib>El-Hajj Fuleihan, Ghada</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolism, clinical and experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hage, Mirella P</au><au>Salti, Ibrahim</au><au>El-Hajj Fuleihan, Ghada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism</atitle><jtitle>Metabolism, clinical and experimental</jtitle><addtitle>Metabolism</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>61</volume><issue>6</issue><spage>762</spage><epage>775</epage><pages>762-775</pages><issn>0026-0495</issn><eissn>1532-8600</eissn><abstract>Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22221828</pmid><doi>10.1016/j.metabol.2011.11.001</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-0495
ispartof Metabolism, clinical and experimental, 2012-06, Vol.61 (6), p.762-775
issn 0026-0495
1532-8600
language eng
recordid cdi_proquest_miscellaneous_1017620544
source MEDLINE; Elsevier ScienceDirect Journals
subjects Biological and medical sciences
Endocrinology & Metabolism
Endocrinopathies
Feeding. Feeding behavior
Fundamental and applied biological sciences. Psychology
Humans
Hyperparathyroidism - etiology
Hyperparathyroidism - surgery
Medical sciences
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Parathyroid Glands - surgery
Parathyroidectomy
Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)
Recurrence
Vertebrates: anatomy and physiology, studies on body, several organs or systems
title Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T09%3A45%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parathyromatosis:%20a%20rare%20yet%20problematic%20etiology%20of%20recurrent%20and%20persistent%20hyperparathyroidism&rft.jtitle=Metabolism,%20clinical%20and%20experimental&rft.au=Hage,%20Mirella%20P&rft.date=2012-06-01&rft.volume=61&rft.issue=6&rft.spage=762&rft.epage=775&rft.pages=762-775&rft.issn=0026-0495&rft.eissn=1532-8600&rft_id=info:doi/10.1016/j.metabol.2011.11.001&rft_dat=%3Cproquest_cross%3E1017620544%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017620544&rft_id=info:pmid/22221828&rft_els_id=S0026049511003659&rfr_iscdi=true